raloxifene has been researched along with cyclofenil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hashimoto, Y; Makishima, M; Nanjyo, S; Noguchi-Yachide, T; Ohgane, K; Yoshioka, H | 1 |
1 review(s) available for raloxifene and cyclofenil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for raloxifene and cyclofenil
| Article | Year |
|---|---|
Structure-activity relationship study of estrogen receptor down-regulators with a diphenylmethane skeleton.
Topics: Benzhydryl Compounds; Binding Sites; Cyclofenil; Down-Regulation; Estrogen Antagonists; Estrogen Receptor alpha; HEK293 Cells; Humans; Molecular Docking Simulation; Phenols; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2019 |